Treatment of rheumatoid arthritis with biological agents — as a typical and common immune-mediated inflammatory disease
-
- TAKEUCHI Tsutomu
- Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine
Bibliographic Information
- Other Title
-
- Treatment of rheumatoid arthritis with biological agents : as a typical and common immune-mediated inflammatory disease
Search this article
Abstract
<p>Molecules involved in the disease process facilitated our understanding of pathogenesis of the disease with unknown etiology such as immune-mediated and inflammatory diseases. Moreover, the targeted therapies against the proposed molecular targets by biological agents provide enormous benefits to the patients and societies. Here, I will review recent progress of the biological treatment in the immune-inflammatory diseases by focusing on the rheumatoid arthritis, the disease characterized by persistent polyarthritis leading to joint destruction and disability with autoimmune features, as a role model.</p>
Journal
-
- Proceedings of the Japan Academy, Series B
-
Proceedings of the Japan Academy, Series B 93 (8), 600-608, 2017
The Japan Academy
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679124473728
-
- NII Article ID
- 130006164480
-
- NII Book ID
- AA00785485
-
- ISSN
- 13492896
- 03862208
-
- NDL BIB ID
- 028634881
-
- PubMed
- 29021510
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed